Proprietor, Pharm Astute |
Former Assistant Commissioner (Drugs), |
Food and Drug Administration, Maharashtra, Mumbai. |
Email: dargandhi@gmail.com |
Cell: +91 989-257-1392 |
www.pharmastute.com |
- Decoding the Jan Vishwas Act on penalties for NSQ drug offenses - November 29, 2023
- Jan Vishwas Act: Transforming Penalties for Drug Advertising Offenses - October 14, 2023
- Amendment in D&C Act: Decriminalizing Offences for Trust-Based Governance - September 30, 2023
Last Updated on December 24, 2023 by The Health Master
Jan Vishwas Act
Jan Vishwas Act: Regulatory experts shed light on the scarcity of cases filed for the violation of Section 29 of the Drugs and Cosmetics (D&C) Act, 1940 in the context of discussions surrounding the decriminalization of offenses under the same act.
The recent amendment to Section 29 comes as a part of the Jan Vishwas (Amendment of Provisions) Act, 2023, a significant development in drug regulatory measures.
This section deals with penalties for the use of a Government Analyst’s report for advertising purposes.
The Revised Provisions
The amended Section 29 of the Jan Vishwas Act brings about notable changes in the penalties associated with contravention.
Formerly, fines could extend up to five thousand rupees; now, they can be as high as one lakh rupees.
This substantial increase aims to enforce stricter compliance with advertising regulations in the pharmaceutical industry.
Expert Insights
Nilesh Gandhi, proprietor of Pharm Astute and former assistant commissioner (Drugs) at the Food and Drug Administration, Mumbai, expressed his perspective on the amendment.
He emphasized that, to the best of their knowledge, there have been few, if any, instances of individuals being convicted under Section 29 of the Act.
This amendment, therefore, may hold more academic interest than immediate practical impact.
Understanding the Existing Act
SW Deshpande, a legal expert from Pharmalex Complete Legal Solutions and former joint commissioner at the Maharashtra Food and Drug Administration (FDA), provided a detailed explanation of the existing provisions.
Under the current D&C Act, any individual using a report or analysis from the Central Drugs Laboratory (CDL) or a Government Analyst for advertising drugs or cosmetics could face fines up to five thousand rupees.
Revisiting Section 30(2)
Section 30(2) of the Act addresses subsequent offenses related to advertising Government Analyst Reports.
It stipulates that a person previously convicted under Section 29, who is convicted again under the same section, could face imprisonment for up to two years or a fine of not less than ten thousand rupees, or both.
The Jan Vishwas Impact on Section 30(2)
The Jan Vishwas Act also brings changes to Section 30(2), specifically concerning penalties for subsequent offenses.
The amendment removes the possibility of imprisonment for up to two years, leaving a substantial fine of not less than five lakh rupees as the sole penalty.
This modification reflects a shift towards heavier financial penalties for repeat offenses, aiming to deter non-compliance.
Disclaimer: The views expressed are solely those of the author, and TheHealthMaster.com does not necessarily subscribe to them. TheHealthMaster.com shall not be responsible for any damage caused to any person / organization, directly or indirectly.
USFDA approval granted for this inflammatory bowel disease drug
USFDA issues Form 483 with 9 observation to Dr Reddy’s laboratories: Hyderabad
Regulatory Changes: Relief for Class C and D Medical Device in India
Govt Job: Unlocking Opportunities for CDSCO Recruitment 2023
Understanding the New Price Regulations for Orthopaedic Knee Implants: NPPA
Drug recall: These injections recalled due to Glass Particulate Matter
IPC: Indian Pharmacopoeia Commission joins the Pharmacopoeial Discussion Group
USFDA issues Form 483 with one observation to Aurobindo Unit IV: Andhra Pradesh
Pakistan: New technology introduced for instant detection of spurious drugs
Importance of Humidity Control in Pharmaceutical Industry
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
